We help, we care.
APIE Limited, as part of the Aspire Pharma group, distributes quality branded and generic medicines and is the pharmaceutical entrepreneur and distributor for Aspire Pharma in Germany. Consequently, you will find all our medicines listed under the company name APIE Limited in your clinical and pharmacy systems.
Our mission
To make a difference in the lives of patients through the development and supply of innovative products and medicines throughout the world.
“We are entering the German generics market with a clear purpose: to address therapeutic gaps by delivering high-quality hard to produce molecules, and targeted treatments for underserved and rare conditions. We help, we care and are committed to providing quality and value to support the highest level of patient care.”
Katharina Pink
Chief Commercial Officer – Germany
Hospital Orders
Storage, logistics and customer service are provided through our specialised pharmaceutical wholesale partner L&L Pharma GmbH.
The Customer Service team handles hospital, pharmacy and pharmaceutical wholesaler orders, as well as product availability enquiries and returns requests, Monday to Friday from 8:00 am to 5:00 pm (CET).
Telephone: +49 (0) 62 52 – 942 82 22
Fax: +49 (0) 62 52 – 942 82 23
Email: [email protected]
Who we are
We are a specialty niche generics pharma business, based in the UK with global ambitions, devoted to delivering true value to patients, healthcare professionals and national health systems.
Our values
Accountability
Collaboration
Inclusivity
Innovation
Integrity
Who we are
We are a specialty niche generics pharma business, based in the UK with global ambitions, devoted to delivering true value to patients, healthcare professionals and national health systems.
Our values
Accountability
Collaboration
Inclusivity
Innovation
Integrity
“Aspire Pharma’s founding principle was to take a medicine, a molecule or a device and enhance it. This might be an improved presentation, a more convenient dose, or a more acceptable formulation for patients, and that principle still drives what we do today.”
Richard Condon
Aspire Pharma Chief Executive
MAT-DE-COR-0004-2 | August 2026
